Literature DB >> 10632661

Development of dextran sulphate sodium-induced experimental colitis is suppressed in genetically mast cell-deficient Ws/Ws rats.

Y Araki1, A Andoh, Y Fujiyama, T Bamba.   

Abstract

Ws/Ws rats have a small deletion of the c-kit gene, and are deficient in both mucosal-type mast cells (MMC) and connective tissue-type mast cells (CTMC). In the present study we investigated the role of intestinal MMC in the development of dextran sulphate sodium (DSS)-induced experimental colitis using Ws/Ws rats. Ws/Ws and control (+/+) rats were given a 3% DSS aqueous solution orally for 10 days, and the subsequent mucosal damage was evaluated macroscopically and histologically. The mucosal myeloperoxidase (MPO) activities and histamine levels were also measured. (i) DSS induced severe oedema and hyperaemia with sporadic erosions in the control (+/+) rats, but these changes were significantly attenuated in the Ws/Ws rats (P < 0.01). (ii) The microscopic mucosal damage score was lower in the Ws/Ws rats than in the control (+/+) rats (P = 0.06). (iii) There were no significant differences in mucosal MPO activity between the Ws/Ws and control (+/+) rats (P = 0.46). (iv) The mucosal histamine levels in the colon were significantly reduced in the Ws/Ws rats compared with the control (+/+) rats (P < 0.05). (v) Significant positive correlations were observed between mucosal histamine levels and the degree of mucosal oedema (calculated as colonic wet weight/protein content) (r = 0.778, P < 0.01), and between histamine levels and the macroscopic damage (r = 0.623, P < 0.05), respectively. (vi) DSS induced a local recruitment of MMC in the colonic mucosa of Ws/Ws rats, and mucosal damage gradually increased in accordance with this MMC recruitment. These results indicate that MMC play an important role in the development of DSS colitis.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10632661      PMCID: PMC1905515          DOI: 10.1046/j.1365-2249.2000.01094.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  30 in total

1.  Mast cells in inflammatory conditions of the gastrointestinal tract.

Authors:  R B HIATT; L KATZ
Journal:  Am J Gastroenterol       Date:  1962-05       Impact factor: 10.864

2.  The role of the intestinal microflora in experimental colitis.

Authors:  A B Onderdonk; J A Hermos; J G Bartlett
Journal:  Am J Clin Nutr       Date:  1977-11       Impact factor: 7.045

3.  A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice.

Authors:  I Okayasu; S Hatakeyama; M Yamada; T Ohkusa; Y Inagaki; R Nakaya
Journal:  Gastroenterology       Date:  1990-03       Impact factor: 22.682

Review 4.  Mediators of immediate hypersensitivity.

Authors:  S I Wasserman
Journal:  J Allergy Clin Immunol       Date:  1983-08       Impact factor: 10.793

5.  Role of lysosomes in carrageenan-induced cecal ulceration.

Authors:  R Abraham; R J Fabian; L Golberg; F Coulston
Journal:  Gastroenterology       Date:  1974-12       Impact factor: 22.682

6.  Crohn's disease: transmission electron microscopic studies. II. Immunologic inflammatory response. Alterations of mast cells, basophils, eosinophils, and the microvasculature.

Authors:  A M Dvorak; R A Monahan; J E Osage; G R Dickersin
Journal:  Hum Pathol       Date:  1980-11       Impact factor: 3.466

7.  Chymotrypsin- and trypsin-type serine proteases in rat mast cells: properties and functions.

Authors:  H Kido; N Fukusen; N Katunuma
Journal:  Arch Biochem Biophys       Date:  1985-06       Impact factor: 4.013

8.  Biopsy histamine in ulcerative colitis and Crohn's disease.

Authors:  H W Baenkler; G Lux; R Günthner; M Kohlhäufl; W Matek
Journal:  Hepatogastroenterology       Date:  1987-12

9.  T lymphocyte subpopulations and immunoglobulin-containing cells in the colonic mucosa of ulcerative colitis; a morphometric and immunohistochemical study.

Authors:  K Kobayashi; H Asakura; Y Hamada; T Hibi; M Watanabe; T Yoshida; N Watanabe; S Miura; S Aiso; M Tsuchiya
Journal:  J Clin Lab Immunol       Date:  1988-02

10.  The intestinal mast cell response to Trichinella spiralis infection in mast cell-deficient w/wv mice.

Authors:  H Alizadeh; K D Murrell
Journal:  J Parasitol       Date:  1984-10       Impact factor: 1.276

View more
  22 in total

1.  Mast cells enhance T cell activation: Importance of mast cell-derived TNF.

Authors:  Susumu Nakae; Hajime Suto; Maki Kakurai; Jonathon D Sedgwick; Mindy Tsai; Stephen J Galli
Journal:  Proc Natl Acad Sci U S A       Date:  2005-04-19       Impact factor: 11.205

2.  Type I interferons attenuate T cell activating functions of human mast cells by decreasing TNF-alpha production and OX40 ligand expression while increasing IL-10 production.

Authors:  Tomoko Fujita; Naotomo Kambe; Takashi Uchiyama; Toshiyuki Hori
Journal:  J Clin Immunol       Date:  2006-09-19       Impact factor: 8.317

3.  Indirect involvement of allergen-captured mast cells in antigen presentation.

Authors:  Taku Kambayashi; Jan D Baranski; Rebecca G Baker; Tao Zou; Eric J Allenspach; Jonathan E Shoag; Peter L Jones; Gary A Koretzky
Journal:  Blood       Date:  2007-11-21       Impact factor: 22.113

4.  The role of mast cells in bacterial enteritis.

Authors:  Melanie A Sherman
Journal:  Am J Pathol       Date:  2007-06-14       Impact factor: 4.307

Review 5.  The multifaceted mast cell in inflammatory bowel disease.

Authors:  Matthew J Hamilton; Sandra M Frei; Richard L Stevens
Journal:  Inflamm Bowel Dis       Date:  2014-12       Impact factor: 5.325

6.  Kit (W-sh) mice develop earlier and more severe experimental autoimmune encephalomyelitis due to absence of immune suppression.

Authors:  Hongmei Li; Bardia Nourbakhsh; Farinaz Safavi; Ke Li; Hui Xu; Melissa Cullimore; Fang Zhou; Guangxian Zhang; Abdolmohamad Rostami
Journal:  J Immunol       Date:  2011-06-06       Impact factor: 5.422

7.  Development of colorectal sensitization is associated with increased eosinophils and mast cells in dextran sulfate sodium-treated rats.

Authors:  J M Tobin; L M D Delbridge; R Di Nicolantonio; P Bhathal
Journal:  Dig Dis Sci       Date:  2004-08       Impact factor: 3.199

Review 8.  Key role of mast cells and their major secretory products in inflammatory bowel disease.

Authors:  Shao-Heng He
Journal:  World J Gastroenterol       Date:  2004-02-01       Impact factor: 5.742

9.  Inducible MHC class II expression by mast cells supports effector and regulatory T cell activation.

Authors:  Taku Kambayashi; Eric J Allenspach; John T Chang; Tao Zou; Jonathan E Shoag; Steven L Reiner; Andrew J Caton; Gary A Koretzky
Journal:  J Immunol       Date:  2009-04-15       Impact factor: 5.422

10.  Zinc transporter Znt5/Slc30a5 is required for the mast cell-mediated delayed-type allergic reaction but not the immediate-type reaction.

Authors:  Keigo Nishida; Aiko Hasegawa; Susumu Nakae; Keisuke Oboki; Hirohisa Saito; Satoru Yamasaki; Toshio Hirano
Journal:  J Exp Med       Date:  2009-05-18       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.